In the news release, Boston Biomedica (Nasdaq: BBII) Reports Improved Second Quarter Financial Results, issued earlier today over PR Newswire, we are advised by the company that the first paragraph, first sentence should read "... compared with revenue of $5,856,096 for the three months ended June 30, 2002" rather than "...June 30, 2003" and the first paragraph, second sentence should read "...operating loss of $(156,338) in the second quarter of 2003, compared to an operating loss of $(247,487) in the second quarter of 2002" rather than "...operating loss of $(156,338) in the first quarter of 2003, compared to an operating loss of $(247,487) in the first quarter of 2002". Also the sixth sentence in the forward looking statement paragraph, should read "...the Company's ten issued US patents..." rather than "...the Company's nine issued US patents..." as originally issued inadvertently.
SOURCE Boston Biomedica, Inc.
